ESCALON MEDICAL Business Summary

Escalon Medical Corp (ESMC) operates as a specialized healthcare company focused on the development, manufacture, and global distribution of ophthalmic medical devices and pharmaceuticals. The company generates revenue primarily through product sales and recurring service contracts across three core business segments: Sonomed (ultrasound diagnostics), Trek (surgical products and intraocular gases), and digital imaging solutions. Its product portfolio includes high-frequency A-scan and B-scan ultrasound systems, UBM devices, and surgical packs. In a significant strategic shift as of January 2026, the company monetized its non-core AXIS image management platform by selling the software assets to Optos for $3.0 million to improve liquidity. Escalon competes directly with industry players such as Quantel Medical, Accutome (Halma plc), and Ellex Medical Lasers, maintaining a niche market position by leveraging its 30-year reputation in ultrasound biometry and proprietary technological innovation. The company’s leadership is characterized by long-term stability and insider control, currently led by Richard J. DePiano, Jr., who serves as Chairman, CEO, President, and General Counsel. DePiano, Jr. joined the firm in 2000 and succeeded his father, founder Richard J. DePiano, Sr., in 2013, bringing a background in corporate law and operational management. Supporting him is Mark G. Wallace, who serves as Chief Operating Officer, Principal Financial Officer, and Principal Accounting Officer, alongside Weiying Huang, the Vice President of Finance. The Board of Directors includes seasoned independent members such as Lisa Napolitano, David J. Jacovini, and John P. Dogum. While the company is publicly traded on the OTCQB, it remains largely controlled by the DePiano estate, with minimal institutional ownership and a focus on lean operations and strategic partnerships.